SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Remedent, Inc. – ‘10-Q’ for 12/31/20 – ‘EX-31.2’

On:  Tuesday, 2/16/21, at 4:30pm ET   ·   For:  12/31/20   ·   Accession #:  1104659-21-24103   ·   File #:  1-15975

Previous ‘10-Q’:  ‘10-Q’ on 11/16/20 for 9/30/20   ·   Latest ‘10-Q’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/16/21  Remedent, Inc.                    10-Q       12/31/20   66:4.2M                                   Toppan Merrill/FA

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    180K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     24K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     24K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     19K 
12: R1          Document And Entity Information                     HTML     50K 
13: R2          Consolidated Balance Sheets                         HTML    110K 
14: R3          Consolidated Balance Sheets (Parenthetical)         HTML     41K 
15: R4          Consolidated Statements of Operations               HTML    107K 
16: R5          Consolidated Statements of Comprehensive Income     HTML     43K 
                (Loss)                                                           
17: R6          Consolidated Statements of Cash Flows               HTML     75K 
18: R7          Description of the Company and Basis of             HTML     25K 
                Presentation                                                     
19: R8          Summary of Significant Accounting Policies          HTML     57K 
20: R9          Long-Term Investments                               HTML     88K 
21: R10         Concentration of Risk                               HTML     23K 
22: R11         Accounts Receivable and Allowance for Doubtful      HTML     33K 
                Accounts                                                         
23: R12         Inventories                                         HTML     41K 
24: R13         Prepaid Expenses and Other Assets                   HTML     38K 
25: R14         Property and Equipment                              HTML     39K 
26: R15         Due to Related Parties and Related Party            HTML     23K 
                Transactions                                                     
27: R16         Accrued Liabilities                                 HTML     53K 
28: R17         Equity Compensation Plans                           HTML     67K 
29: R18         Segment Information                                 HTML     25K 
30: R19         Leases                                              HTML     70K 
31: R20         Financial Instruments                               HTML    108K 
32: R21         Summary of Significant Accounting Policies          HTML     70K 
                (Policies)                                                       
33: R22         Summary of Significant Accounting Policies          HTML     43K 
                (Tables)                                                         
34: R23         Long-Term Investments (Tables)                      HTML     78K 
35: R24         Accounts Receivable and Allowance for Doubtful      HTML     33K 
                Accounts (Tables)                                                
36: R25         Inventories (Tables)                                HTML     41K 
37: R26         Prepaid Expenses and Other Assets (Tables)          HTML     38K 
38: R27         Property and Equipment (Tables)                     HTML     38K 
39: R28         Accrued Liabilities (Tables)                        HTML     53K 
40: R29         Equity Compensation Plans (Tables)                  HTML     65K 
41: R30         Leases (Tables)                                     HTML     69K 
42: R31         Financial Instruments (Tables)                      HTML    107K 
43: R32         Description of the Company and Basis of             HTML     24K 
                Presentation (Details)                                           
44: R33         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     25K 
                Product warranty liability (Details)                             
45: R34         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     65K 
                Additional information (Details)                                 
46: R35         Long-Term Investments (Details)                     HTML     43K 
47: R36         Long-Term Investments - Summary of represent the    HTML     48K 
                summary financial information derived from its                   
                financial statements and prepared under US GAAP                  
                (Details)                                                        
48: R37         LONG-TERM INVESTMENTS - Additional information      HTML    251K 
                (Details)                                                        
49: R38         Concentration of Risk (Details)                     HTML     33K 
50: R39         Accounts Receivable and Allowance for Doubtful      HTML     26K 
                Accounts (Details)                                               
51: R40         Inventories (Details)                               HTML     32K 
52: R41         Prepaid Expenses and Other Assets (Details)         HTML     31K 
53: R42         Property and Equipment (Details)                    HTML     31K 
54: R43         Due to Related Parties and Related Party            HTML     21K 
                Transactions (Details)                                           
55: R44         Accrued Liabilities (Details)                       HTML     43K 
56: R45         EQUITY COMPENSATION PLANS - Equity compensation     HTML     27K 
                plans approved and not approved by shareholders                  
                (Details)                                                        
57: R46         EQUITY COMPENSATION PLANS - Additional information  HTML     25K 
                (Details)                                                        
58: R47         Segment Information (Details)                       HTML     20K 
59: R48         LEASES - Right-of-use assets and related            HTML     27K 
                liabilities (Details)                                            
60: R49         LEASES - Maturities of lease liabilities (Details)  HTML     33K 
61: R50         LEASES - Additional information (Details)           HTML     28K 
62: R51         FINANCIAL INSTRUMENTS - Carrying values and fair    HTML     63K 
                values (Details)                                                 
63: R52         FINANCIAL INSTRUMENTS - Additional information      HTML     26K 
                (Details)                                                        
65: XML         IDEA XML File -- Filing Summary                      XML    116K 
64: EXCEL       IDEA Workbook of Financial Reports                  XLSX     70K 
 6: EX-101.INS  XBRL Instance -- remi-20201231                       XML   1.24M 
 8: EX-101.CAL  XBRL Calculations -- remi-20201231_cal               XML    150K 
 9: EX-101.DEF  XBRL Definitions -- remi-20201231_def                XML    241K 
10: EX-101.LAB  XBRL Labels -- remi-20201231_lab                     XML    756K 
11: EX-101.PRE  XBRL Presentations -- remi-20201231_pre              XML    563K 
 7: EX-101.SCH  XBRL Schema -- remi-20201231                         XSD    135K 
66: ZIP         XBRL Zipped Folder -- 0001104659-21-024103-xbrl      Zip    105K 


‘EX-31.2’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

EXHIBIT 31.2

 

OFFICER’S CERTIFICATE

PURSUANT TO SECTION 302

 

I, Philippe Van Acker, certify that:

 

  1. I have reviewed this Quarterly Report on Form 10-Q of Remedent, Inc.
     
  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
     
  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
     
  4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
     
  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
     
  5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):
     
  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.
       

Date:        February 16, 2021 By: /s/ Philippe Van Acker
    Name: Philippe Van Acker
    Title: Chief Financial Officer
(Principal Financial and Accounting Officer)

 

 C: 

 

 


Dates Referenced Herein

This ‘10-Q’ Filing    Date    Other Filings
Filed on:2/16/21None on these Dates
For Period end:12/31/20
 List all Filings 
Top
Filing Submission 0001104659-21-024103   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 10:13:09.1pm ET